AJMC July 17, 2024
While the risk of developing long COVID after a SARS-CoV-2 infection remains a persistent threat, it decreased significantly over the course of the COVID-19 pandemic. The decline is largely attributed to vaccination against COVID-19, according to a new study published in New England Journal of Medicine (NEJM).1
Ziyad Al-Aly, MD, a clinical epidemiologist with Washington University School of Medicine in St. Louis and a nephrologist at John J. Cochran Veterans Hospital in St. Louis, said the declining rates of long COVID is a rare occasion of good news regarding COVID-19.2 However, he emphasized that long COVID remains a challenge.
Presentation and Prevalence of Long COVID
Long COVID, or postacute sequelae of SARS-CoV-2 (PASC), affects many organ systems, and the risk...